New SEC Form D filing

OS Therapies Inc, 2026-08-25

A new SEC Form D private-offering notice from Grasonville, MD, a $10,000,000 filer-stated offering target in Biotech. The source filing is one click away.

What this filing says

OS Therapies Inc site↗ Verified via SEC Form D

Clinical-stage biopharmaceutical company developing HER2-targeted immunotherapies for osteosarcoma and other solid tumors

Filed 2026-08-25Filed to raise $10,000,000First money in 2026-08-10Raised so far $5,000,000HQ (as filed) Grasonville, MDSector Biotech web-verified against the company’s own siteStage (inferred) EarlyCall status Call-ready
Source linked the Form D on EDGAR↗Website verified ostherapies.com↗Named in the filing 8 executives & directors
Open this row on the live feed →More new filings in Maryland →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.

Other Form D filings from the same week

each with its own page and its own EDGAR source